News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25
Rami Manochakian/X
Jun 3, 2025, 09:48

Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, posted on X:

“Hot Off The Press, Just presented at ASCO25.

Results of ALNEO phase 2 trial of: Neoadjuvant and Alectinib in potentially resectable stage Ill ALK+ Non-Small Cell Lung Cancer

  • pCR: 12%
  • MPR: 46%
  • ORR: 67%
  • Safety profile consistent with previous studies.”

Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25

See also:

ALNEO phase 2 trial ASCO25 cancer non small cell lung cancer OncoDaily Oncology Rami Manochakian
Special Coverage
Career
Jun 4, 2025, 17:30
Fellowship and Short-Term Training Opportunities Now Open at POEM Training Centers - POEM Group
Celebrities
Jun 4, 2025, 17:16
Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?
Blog
Jun 4, 2025, 17:13
Katy Rezvani Has Been Appointed as AACR 2026 Program Committee Co-Chair and Elected to the Association of American Physicians
Blog
Jun 4, 2025, 17:07
Teresa Amaral: The Fantastic Faculty of The ASCO and ESMO Session at ASCO25 Congress
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)
Blog
Jun 4, 2025, 15:56
SIOG Announces Interactive Geriatric Assessment Workshop for SIOG 2025